Chain Drug Review - Daiichi launches Welchol
March 17, 2008 -- PARSIPPANY, N.J. -- Daiichi Sankyo Inc. has received Food and Drug Administration approval of Welchol (colesevelam HCl) to improve glycemic control...
Chain Drug Review - WelChol gets FDA O.K
February 4, 2008 -- The Food and Drug Administration has approved WelChol tablets as an adjunct treatment to diet and exercise for improving glycemic control in adults...
Market Wire - Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults With Type 2 Diabetes
January 21, 2008 -- Daiichi Sankyo, Inc. announced today thatthe United States Food and Drug Administration (FDA) has approvedWelchol(TM) (colesevelam HCl) to improve...
Market Wire - Data From Pooled Analyses Demonstrates Welchol, Combined With Metformin -- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults With...
May 16, 2008 -- Daiichi Sankyo, Inc. (DSI) announced todaythat data from two pooled analyses further demonstrate that Welchol(TM)(colesevelam HCl), in combination...
Market Wire - Daiichi Sankyo, Inc. Announces Filing for WelChol Label Change to Include Ezetimibe Efficacy Data
March 28, 2007 -- Daiichi Sankyo, Inc. announced today that ithas filed for a label change with the U.S. Food and Drug Administration toinclude ezetimibe efficacy data...
Market Wire - Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated
May 30, 2008 -- Daiichi Sankyo, Inc., announced today thatdata from post-hoc analyses of three pivotal studies demonstrated that theaddition of Welchol(TM),...
Market Wire - Welchol(TM) Added to the American College of Endocrinology/American Association of Clinical Endocrinologists "Road Maps to Achieve Glycemic Control in...
April 15, 2008 -- Daiichi Sankyo announced today thatWelchol(TM) (colesevelam HCl) has been added to the American College ofEndocrinology (ACE) and American...
Market Wire - New Study Confirms WelChol Improves Glycemic Control in Patients With Uncontrolled Type 2 Diabetes Mellitus on Insulin
November 15, 2006 -- Data presented today at the American HeartAssociation's (AHA) Scientific Sessions 2006 in Chicago demonstrated thatWelChol® (colesevelam HCl),...
Market Wire - WelChol and Ezetimibe Combination Therapy Provides Significant LDL-C Reductions
November 13, 2006 -- A new study found that taking WelChol®(colesevelam HCI) in combination with ezetimibe reduced LDL-C by 32%,reducing mean LDL-C levels by an...
Market Wire - Daiichi Sankyo, Inc. Announces Filing of Supplemental New Drug Application for WelChol in the Treatment of Type 2 Diabetes Mellitus
January 2, 2007 -- Daiichi Sankyo, Inc. announced today that ithas filed a supplemental New Drug Application (sNDA) with the U.S. Food andDrug Administration (FDA) for...
